MedPath

Multi-center retrospective study of prognostic significance of histological subtypes and expression of immunomolecules in adenocarcinoma of the uterine cervix

Not Applicable
Conditions
Adenocacinoma of the uterine cervix
Registration Number
JPRN-UMIN000027823
Lead Sponsor
Gunma university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Female
Target Recruitment
71
Inclusion Criteria

Not provided

Exclusion Criteria

(1)prior treatment (2)no bioptic sample (3)other malignancies (except no recurrence cases 5 years after definitive treatments)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
5-year overall survival
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath